GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi India Ltd (NSE:SANOFI) » Definitions » Cyclically Adjusted PS Ratio

Sanofi India (NSE:SANOFI) Cyclically Adjusted PS Ratio : 6.59 (As of Jun. 10, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Sanofi India Cyclically Adjusted PS Ratio?

As of today (2024-06-10), Sanofi India's current share price is ₹9573.65. Sanofi India's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was ₹1,451.88. Sanofi India's Cyclically Adjusted PS Ratio for today is 6.59.

The historical rank and industry rank for Sanofi India's Cyclically Adjusted PS Ratio or its related term are showing as below:

NSE:SANOFI' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 3.85   Med: 5.69   Max: 7.32
Current: 6.59

During the past years, Sanofi India's highest Cyclically Adjusted PS Ratio was 7.32. The lowest was 3.85. And the median was 5.69.

NSE:SANOFI's Cyclically Adjusted PS Ratio is ranked worse than
88.02% of 743 companies
in the Drug Manufacturers industry
Industry Median: 2.06 vs NSE:SANOFI: 6.59

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Sanofi India's adjusted revenue per share data for the three months ended in Dec. 2023 was ₹286.713. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₹1,451.88 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sanofi India Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Sanofi India's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi India Cyclically Adjusted PS Ratio Chart

Sanofi India Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.90 6.72 5.97 4.20 5.56

Sanofi India Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.20 4.08 4.81 4.99 5.56

Competitive Comparison of Sanofi India's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - General subindustry, Sanofi India's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanofi India's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanofi India's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Sanofi India's Cyclically Adjusted PS Ratio falls into.



Sanofi India Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Sanofi India's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=9573.65/1451.88
=6.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sanofi India's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Sanofi India's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=286.713/152.9243*152.9243
=286.713

Current CPI (Dec. 2023) = 152.9243.

Sanofi India Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 193.452 91.425 323.583
201406 219.560 94.103 356.803
201409 223.646 96.780 353.387
201412 214.565 96.780 339.038
201503 212.537 97.163 334.511
201506 238.544 99.841 365.374
201509 254.685 101.753 382.764
201512 226.392 102.901 336.448
201603 241.935 102.518 360.889
201606 269.617 105.961 389.114
201609 277.454 105.961 400.425
201612 263.240 105.196 382.674
201703 240.423 105.196 349.505
201706 261.108 107.109 372.797
201709 290.243 109.021 407.124
201712 274.712 109.404 383.991
201803 268.204 109.786 373.588
201806 297.192 111.317 408.276
201809 323.419 115.142 429.545
201812 294.230 115.142 390.778
201903 311.477 118.202 402.974
201906 324.736 120.880 410.822
201909 338.224 123.175 419.912
201912 332.667 126.235 403.000
202003 340.628 124.705 417.708
202006 308.497 127.000 371.469
202009 298.146 130.118 350.404
202012 298.033 130.889 348.207
202103 314.837 131.771 365.379
202106 342.640 134.084 390.784
202109 327.602 135.847 368.785
202112 284.226 138.161 314.598
202203 306.964 138.822 338.148
202206 303.647 142.347 326.209
202209 300.434 144.661 317.595
202212 273.110 145.763 286.528
202303 319.786 146.865 332.981
202306 306.627 150.280 312.022
202309 310.251 151.492 313.184
202312 286.713 152.924 286.713

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sanofi India  (NSE:SANOFI) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Sanofi India Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Sanofi India's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanofi India (NSE:SANOFI) Business Description

Traded in Other Exchanges
Address
Saki Vihar Road, Sanofi House, CTS Number 117-B, L&T Business Park, Powai, Mumbai, MH, IND, 400072
Sanofi India Ltd is a drug manufacturing company that focuses on a range of therapeutic areas, including Diabetes, Cardiology, Consumer Healthcare, Hospital, Central Nervous System, and Anti-Histamines. The company's diabetes presence includes oral anti-diabetic products and insulin. The consumer healthcare area also maintains a nutraceutical portfolio. The company's export markets include Germany, the U.K., Australia, and Russia. The company utilizes strategic partnerships as a component of its growth strategy.

Sanofi India (NSE:SANOFI) Headlines

No Headlines